Author

admin

Browsing

NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario Securities Commission, has granted its request for a management cease trade order (‘MCTO’) effective May 8, 2025.

As previously announced on April 29, 2025, the Company applied for the MCTO due to a delay in filing its annual audited financial statements, management’s discussion and analysis and related certifications for the financial year ended December 31, 2024 (the ‘Annual Filings’) which were required to be filed by April 30, 2025.

The delay is primarily due to a restatement of certain amounts owed by the Company’s payment service providers as well as player loyalty bonuses for the prior fiscal years. During the year-end reconciliation process, the Company identified that its payment processor had deducted additional merchant fees from daily remittances, which had not been properly accounted for. Specifically, service provider fees (cost of revenue) were previously understated, while the amounts due from the payment processor and accounts receivable were overstated in the financial statements for the year ended December 31, 2023.

The Company is working diligently and expeditiously to complete the Annual Filings as soon as practicable, and currently anticipates it will be in a position to file the Annual Filings on or before May 15, 2025.

The MCTO restricts the Company’s Chief Executive Officer and the Chief Financial Officer from trading in the Company’s securities but does not affect the ability of other shareholders, including the public, to trade in securities of the Company.

About NorthStar

NorthStar proudly owns and operates NorthStar Bets, a Canadian-born casino and sportsbook platform that delivers a premium, distinctly local gaming experience. Designed with high-stakes players in mind, NorthStar Bets Casino offers a curated selection of the most popular games, ensuring an elevated user experience. Our sportsbook stands out with its exclusive Sports Insights feature, seamlessly integrating betting guidance, stats, and scores, all tailored to meet the expectations of a premium audience.

As a Canadian company, NorthStar is uniquely positioned to cater to customers who seek a high-quality product and an exceptional level of personalized service, setting a new standard in the industry. NorthStar is committed to operating at the highest level of responsible gaming standards.

NorthStar is listed in Canada on the TSX Venture Exchange (‘TSXV’) under the symbol ‘BET’ and in the United States on the OTCQB under the symbol ‘NSBBF’. For more information on the company, please visit: www.northstargaming.ca.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Information and Statements

This communication contains ‘forward-looking information’ within the meaning of applicable securities laws in Canada (‘forward-looking statements’), including without limitation, statements with respect to the following: expected performance of the Company’s business, and the timing of the release of the Company’s financial results. The foregoing is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and allowing investors and others to get a better understanding of the Company’s anticipated financial position, results of operations, and operating environment. Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘continues’, ‘forecasts’, ‘projects’, ‘predicts’, ‘intends’, ‘anticipates’ or ‘believes’, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘should’, ‘might’ or ‘will’ be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. This forward-looking information is based on management’s opinions, estimates and assumptions that, while considered by NorthStar to be appropriate and reasonable as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such forward- looking information. Such factors include, among others, the following: risks related to the Company’s business and financial position; risks associated with general economic conditions; adverse industry risks; future legislative and regulatory developments; the ability of the Company to implement its business strategies; and those factors discussed in greater detail under the ‘Risk Factors’ section of the Company’s most recent annual information form, which is available under NorthStar’s profile on SEDAR+ at www.sedarplus.ca. Many of these risks are beyond the Company’s control.

If any of these risks or uncertainties materialize, or if the opinions, estimates or assumptions underlying the forward-looking information prove incorrect, actual results or future events might vary materially from those anticipated in the forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking statements. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents NorthStar’s expectations as of the date specified herein, and are subject to change after such date. However, the Company disclaims any intention or obligation or undertaking to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws.

All of the forward-looking information contained in this press release is expressly qualified by the foregoing cautionary statements.

For further information:

Company Contact:
Corey Goodman
Chief Development Officer 647-530-2387
investorrelations@northstargaming.ca

Investor Relations:
RB Milestone Group LLC (RBMG)
Northstar@rbmilestone.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251431

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a shadow over the psychedelics industry.

However, the sector is seeing a resurgence of optimism in 2025 on the back of various US developments.

“The psychedelic industry in 2025 will likely see significant advancements in clinical applications, particularly in treating PTSD, depression, and addiction, as research continues to validate their therapeutic potential,” Dr. Markus Ploesser, chief innovation officer at Open Mind Health, told Microdose in January.

This sentiment is underscored by a variety of recent positive developments, including the FDA’s approval of Johnson & Johnson’s (NYSE:JNJ) ketamine-derived nasal spray to combat treatment-resistant depression, and an initiative to study MDMA-assisted therapy efficacy for post-traumatic stress disorder (PTSD) and alcohol use disorder in veterans.

In addition, alternative medicine advocate Robert F. Kennedy Jr.’s appointment as head of the US Department of Health and Human Services has created potential for further policy shifts related to mental health and psychedelics research.

Combined, these factors could make 2025 a pivotal year for the industry.

Legal state psychedelics markets take shape

Psychedelic compounds remain federally illegal in the US, but some states have pursued legalization and decriminalization. In November 2020, Oregon became the first state to legalize psilocybin for therapeutic use through the Oregon Psilocybin Services Act. From 2021 to 2022, the Oregon Health Authority and the Psilocybin Advisory Board created rules for the act and began taking applications on January 2, 2023.

Oregon also decriminalized personal possession of all drugs in 2020 through the Drug Addiction Treatment and Recovery Act, which went into effect in February 2021. Many of the provisions in that bill have since been reversed, with the possession of small amounts of hard drugs like fentanyl, methamphetamine and heroin being recriminalized as of September 1, 2024. However, psilocybin remains legal for therapeutic and facilitated use.

As of the end of March, Oregon Psilocybin Services counted 374 state-wide psilocybin facilitators, 29 service centers, 10 manufacturers and 808 worker permits. Satya Therapeutics, located in Ashland, is recognized as one of the state’s most experienced and successful service providers, with roughly 40 to 50 clients serviced monthly.

Publicly traded Florida-based cannabis company Kaya Holdings (OTCQB:KAYS) was awarded a license to operate a psilocybin service center in Oregon through its Fifth Dimension Therapeutics subsidiary in May 2024. Its treatment center, called the Sacred Mushroom, opened its doors in Portland on July 2, 2024.

In 2025, industry advocates are focused on analyzing outcomes from Oregon’s psychedelics program in order to fine tune areas requiring improvement. In February, state lawmakers sought to expand psychedelic therapy through the introduction of HB 3817, which establishes an access pathway for individuals with PTSD to access ibogaine. At the time of this writing, the bill had not yet been scheduled for a public hearing or committee vote.

Despite its growth, affordability has been a barrier to the development of Oregon’s psilocybin therapy program, with sessions typically costing over US$1,500. Some communities in the state also voted to ban psilocybin and psilocybin businesses in 2024, reflecting ongoing public concerns about drug liberalization.

In Colorado, a series of legislative actions regarding psychedelic substances led to state legalization in November 2022. Proposition 122 legalized the regulated access to psilocybin and psilocin in healing centers for adults over 21, decriminalized the personal use and cultivation of these substances and established a Natural Medicine Advisory Board.

SB 23-290, signed in May 2023, amended Proposition 122’s regulations and created a legal framework for healing centers. HB 22-1344, passed in June 2022, paved the way for MDMA-assisted therapy for PTSD if federally approved.

The final rules for licensed psilocybin therapy centers were filed with the secretary of state and became effective on December 15, 2024. Colorado then began accepting applications for licenses. In March, the Department of Revenue issued its first healing center license to the Center Origin in Denver. As of May 2 of this year, there were over 50 pending applications for healing centers, cultivation facilities and manufacturers.

As the psychedelics industry begins to take shape in Colorado, Tasia Poinsatte, the state’s director of the nonprofit Healing Advocacy Fund, told Stateline that centers plan to offer sliding-scale rates and discounts for veterans, Medicaid enrollees and low-income individuals to help address the affordability problem.

New psychedelics laws and research initiatives

Apart from Oregon and Colorado, a wave of legislative activity concerning psychedelics is evident across the US, with states like Illinois, Indiana, Missouri, Maine and New York pursuing various forms of legalization, including decriminalization, research funding and regulated therapeutic programs. Additionally, several cities in Washington and Michigan have decriminalized certain substances, with Washington also considering bills to create a regulated psilocybin services market and to provide funding to study ibogaine for opioid use disorder.

Utah passed legislation in March 2024 to create a program for psilocybin and MDMA as alternative treatments at the University of Utah Health and Intermountain Health. The program began in May 2024 and will run for three years.

Multiple institutions in Maryland, Texas and North Carolina are also conducting studies to assess the efficacy of psychedelics in treating various mental health conditions.

Senate Bill 242 established a working group tasked with studying the therapeutic use of entheogens in Nevada in 2023. A recommendations report was delivered in December 2024, and has garnered support from key legislative figures.

Several cities in California have deprioritized the enforcement of laws against the personal use and possession of certain psychedelics, and the state is considering a psilocybin pilot program for veterans and first responders.

Massachusetts has multiple bills focused on decriminalization and therapeutic pilot programs. In April of this year, New Mexico’s governor signed a bill for a therapeutic psilocybin program.

Meanwhile, Rhode Island has a bill that would legalize psilocybin possession if the federal government reschedules it, and Alaska established a task force in May 2024 to prepare for potential federal legalization of psychedelic therapies.

These actions reflect a shift in psychedelics sentiment and a growing trend of exploring their therapeutic potential.

Psychedelics investing options

To track the financial health of the psychedelic industry, investors can use the Psychedelic Invest Index, which monitors publicly traded companies in the space. Some of the top stocks in the index include Pasithea Therapeutics (NASDAQ:KTTA), MindMed (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS) and Cybin (NYSEAMERICAN:CYBN), all of which are involved in developing psychedelic compounds for mental health treatments.

MindMed has developed a synthetic LSD analog, MM120, currently in Phase III trials for generalized anxiety disorder (GAD) and major depressive disorder (MDD). An oral tablet of MM120 was awarded a patent in July 2024.

Cybin has developed a proprietary deuterated psilocybin analog called CYB003, as well as CYB004, a proprietary deuterated DMT compound; both are protected by patents. The company also acquired SPL028, another deuterated DMT compound, through its merger with Small Pharma in 2023. Phase 2 CYB004 topline safety and efficacy data in GAD is expected in H1 2025. A pivotal study of CYB003 is scheduled for mid-2025.

Meanwhile, Compass Pathways’ Phase 2b randomized controlled study evaluating its synthetic psilocybin therapy, COMP360, was the most extensive psilocybin clinical trial to date. With data presented in 2022, the trial found that one 25 milligram dose of COMP360 resulted in a decline in depressive symptoms after three weeks when combined with psychological guidance, with positive effects reportedly lasting for as long as 12 weeks.

Other key players in the psychedelics market include atai Life Sciences (NASDAQ:ATAI), GH Research (NASDAQ:GHRS), Bright Minds Biosciences (NASDAQ:DRUG) and Silo Pharma (NASDAQ:SILO).

Canadian companies in this sector include Numinus Wellness (TSX:NUMI,OTCQB:MTPLF), Optimi Health (CSE:OPTI,OTCQX:OPTHF), BetterLife Pharma (CSE:BETR,OTCQB:BETRF), Pharmala Biotech (CSE:MDMA,OTCQB:MDXXF) and Restart Life Science (CSE:REST,OTC Pink:NMLSF).

Other avenues for investors include strategic investments in specialized real estate ventures.

Healing Realty Trust (HRT) specializes in acquiring healthcare infrastructure assets, focusing on developing mental and behavioral healthcare facilities. The company established preferred real estate partnership agreements with providers like NeuroSpa, Cambridge Biotherapies and Cathexis in 2024. It has also secured the first tranche of a US$25 million Series A funding round, with the funds earmarked to acquire healthcare facilities in Texas, Ohio and Connecticut.

HRT is reportedly preparing for an initial public offering, with a potential listing in late 2025 or early 2026.

Investor takeaway

Against this backdrop, the psychedelics market could see promising growth in 2025.

While challenges remain, the expansion of legalization and decriminalization, combined with ongoing research, positions the industry for growth and presents potential opportunities for investors.

Securities Disclosure: I, Meagen Seatter, hold direct investment interest in some of the companies mentioned in this article.

This post appeared first on investingnews.com

Edwards grabbed the ankle while on the court. The Timberwolves called timeout, and Edwards limped to the locker room with members of the team’s training staff.

Though the team listed Edwards as questionable to return to the game, he tested the ankle at halftime and was in the lineup to start the third quarter. Just before the third quarter began, the team had said he was available to return.

Edwards had seven points, four rebounds, three assists and three steals and the Timberwolves were ahead 37-19 when he left the game. Returning for the second half, he finished the game with 20 points, nine rebounds, five assists and three steals in 34 minutes as the Timberwolves cruised to a 117-93 win.

‘Feeling great, feeling great,” Edwards told TNT after the game when asked about his ankle.

Injuries continue to play a role in the playoffs. The Cleveland Cavaliers were without Darius Garland, Evan Mobley and De’Andre Hunter in their Game 2 loss to the Indiana Pacers, and Golden State Warriors star Steph Curry is out at least a week with a grade 1 left hamstring strain.

This story has been updated with new information.

The USA TODAY app gets you to the heart of the news — fastDownload for award-winning coverage, crosswords, audio storytelling, the eNewspaper and more.

This post appeared first on USA TODAY

The quest for the top prize in collegiate men’s lacrosse is underway. Over the weekend the remaining 16 teams will be in action, with the ultimate aim of lifting the national championship trophy on Memorial Day in Foxborough, Massachusetts.

Regular followers of the sport will notice a few name-brand programs missing from the NCAA tournament field. Long-time powers Virginia and Johns Hopkins as well as past champions Denver and Loyola (Md.) didn’t make the cut. But that doesn’t necessarily mean we’ll add a new member to the first-time champions club. Most of the seeded teams have won titles before, though it’s been a while for some.

Here’s the weekend schedule, with seeded teams playing on their home fields. The winners will advance to quarterfinal sites next weekend in Hempstead, New York, and Annapolis, Maryland.

NCAA lacrosse tournament title contenders

In a parallel with the recently concluded men’s basketball tournament, there is a team seeking a rare three-peat but facing a difficult path to achieving it. Two-time defending champion Notre Dame is seeking a third title in a row, a feat last accomplished by Princeton from 1996-98. As mentioned, however, it will be a tough path for the Fighting Irish, who did enough to make the field but not enough to earn a seed. They’ll start their title defense on the road at Big Ten tournament champ Ohio State, coincidentally the school that kept the Irish from claiming the crown in football. While it’s undoubtedly the most compelling matchup in the round of 16, the committee did neither team a favor with this pairing. The Buckeyes picked up a 10-9 win at Notre Dame back on March 8, but a season-opening loss to Utah damaged OSU’s overall seed. The game in Columbus isn’t the only rematch of the weekend. Harvard picked up a 15-14 win at Syracuse back on Feb. 22, a result that ultimately helped the Crimson edge out Army for the last at-large spot in the field.

NCAA lacrosse tournament top players

The undisputed star of the sport this year is Cornell’s CJ Kirst. The Tewaaraton Award favorite broke the Division I record for career goals earlier in the season. He enters the tournament with 98 points on 68 goals and 30 assists thus far in the campaign, averaging a lofty 6.53 points per contest. With the help of his friends on the Big Red attack unit, Ryan Goldstein and Michael Long, Cornell leads the nation in scoring at 16.47 goals a game. But one shouldn’t overlook reigning Championship Weekend most outstanding player Chris Kavanagh, back in the tournament for Notre Dame. Other names to know include Syracuse attackman Joey Spallina, Maryland goalkeeper Logan McNaney and Duke do-everything midfielder Andrew McAdorey.

Most likely first-time NCAA lacrosse tournament champion

Ohio State and Penn State have both been to Championship Weekend but have yet to bring home the trophy. Unfortunately, at least one of them won’t be in Foxborough, as they’d be slated to meet in the quarterfinal round should they survive this weekend. Like the Buckeyes, however, the Nittany Lions have a tough draw of their own against a high-scoring Colgate squad that got hot at the right time in the Patriot League tournament.

NCAA lacrosse tournament schedule

(All times Eastern)

First round

Saturday, May 10

Richmond (13-3) at North Carolina (10-4), noon

Towson (11-5) at Princeton (12-3), 2:30 p.m.

Colgate (10-7) at Penn State (10-4), 5 p.m.

Georgetown (11-4) at Duke (12-5), 7:30 p.m.

Sunday, May 11

Notre Dame (8-4) at Ohio State (14-2), noon

Air Force (9-7) at Maryland (11-3), 2:30 p.m.

Harvard (10-4) at Syracuse (11-5), 5 p.m.

Albany (10-8) at Cornell (14-1), 7:30 p.m.

This post appeared first on USA TODAY

With just a couple of weeks remaining in the college baseball regular season, fans are no doubt beginning to ponder how their favorite team’s path to Omaha might be shaping up. The easiest route, of course, involves being one of the top eight seeds that guarantees regional and super regional hosting rights. It is therefore advantageous if your team happens to be in the upper tier of the SEC standings or very high in the ACC hierarchy.

As of now, we project six of the top eight seeds to go to SEC members, with a couple more also slated to host regionals. Texas holds the top seed, but projected No. 2 Arkansas, seeking the program’s first national title, closed the gap with a sweep of the Longhorns last weekend.

The ACC should be well represented as well with three likely hosts among the top 16 teams. National contenders from the west coast are harder to find, but there should be at least three regionals in the Pacific time zone.

So who will occupy those spots and the rest of the field of 64 when it is revealed? Here’s our NCAA baseball tournament bracket projection with less than three weeks to go before Memorial Day:

(* denotes teams that are automatic qualifiers based on current conference standings.)

Austin region

  1. Texas* (1)
  2. Texas-San Antonio*
  3. Xavier
  4. SIU-Edwardsville*

Fayetteville region

  1. Arkansas (2)
  2. Duke
  3. Northeastern*
  4. Central Connecticut State*

Tallahassee region

  1. Florida State* (3)
  2. Florida
  3. Kansas
  4. Bethune-Cookman*

Athens region

  1. Georgia (4)
  2. Miami (Fla.)
  3. Troy
  4. Sacramento State*

Baton Rouge region

  1. LSU (5)
  2. Southern Mississippi
  3. Texas Rio Grande Valley
  4. Missouri State*

Clemson region

  1. Clemson (6)
  2. Dallas Baptist*
  3. Texas A&M
  4. Holy Cross*

Auburn region

  1. Auburn (7)
  2. Georgia Tech
  3. Connecticut
  4. Kent State*

Knoxville region

  1. Tennessee (8)
  2. Louisville
  3. Cal Poly
  4. Bryant*

Chapel Hill region

  1. North Carolina (9)
  2. Mississippi
  3. East Tennessee State*
  4. George Mason*

Nashville region

  1. Vanderbilt (10)
  2. Wake Forest
  3. Southeastern Louisiana*
  4. Oral Roberts*

Morgantown region

  1. West Virginia* (11)
  2. North Carolina State
  3. Mississippi State
  4. Austin Peay*

Corvallis region

  1. Oregon State (12)
  2. Southern California
  3. Arizona State
  4. San Diego*

Myrtle Beach region

  1. Coastal Carolina* (13)
  2. Alabama
  3. Kansas State
  4. High Point*

Los Angeles region

  1. UCLA (14)
  2. Arizona           
  3. Creighton*
  4. Wright State*

Fort Worth region

  1. TCU (15)
  2. Oklahoma
  3. Iowa*
  4. Columbia*

Irvine region

  1. UC Irvine* (16)
  2. Oregon
  3. Fairfield*
  4. Nevada*

Last four in: Troy, Kansas State, Xavier, Texas Rio Grand Valley.

Last four out: Kentucky, Western Kentucky, Michigan, Virginia.

Team breakdown by conference: SEC (13), ACC (9), Big 12 (6), Big Ten (4), Big East (3), Sun Belt (3), Big West (2), Southland (2).

This post appeared first on USA TODAY

It’s official! The opening and closing ceremonies for the 2028 Olympics and Paralympic Games will be hosted at the Los Angeles Memorial Coliseum and SoFi Stadium in Inglewood, California, LA28 announced on May 8.

The real catch is that for the first time in modern Olympics history, the opening ceremonies will be held at two venues at the same time.

While this is a historic occasion for the city of Los Angeles and the Olympics as a whole, the closing ceremonies will not be given the same luxury, though. Instead, the LA Coliseum will be the sole host for the finale.

This marks the third time that LA Coliseum has hosted the summer games (1932, 1984) and the first time for SoFi Stadium, which opened in 2020.

“For over a century, the Coliseum has been a landmark host to some of the most iconic moments in all of sports history,” said L.A. Mayor Karen Bass. “That story continues in 2028 as our City and our region welcomes the world for what will be the greatest Olympic and Paralympic Games.”

When are the 2028 Olympics?

Well, 2028 of course. The opening ceremony is set for July 14, 2028 with the closing ceremony happening two weeks later on July 30. The paralympics, meanwhile, will start on Aug. 15, 2028 and close August 27.

How has the United States done at Olympics hosted in LA?

The United States dominated the 1932 Olympics winning 110 medals in total, the most of the games. In fact, the United States had more gold medals (44) than any other country had total medals. Italy had the second-most medals with 36. They had exactly 12 gold, 12 silver, and 12 bronze.

At the 1984 Olympics, it was more of the same. The United States won 83 gold medals and 174 total medals. Romania finished second with just 20 gold medals, while West Germany tallied the second-most total medals with 59. The United States’ 83 gold medals in those games is an all-time record.

This post appeared first on USA TODAY

Manny Pacquiao plans to end his retirement from boxing at 46 and is set to fight Mario Barrios July 19 in Las Vegas for the WBC welterweight championship, according to an ESPN report.

Pacquiao last fought in 2021, when he lost to Yordenis Ugas by unanimous decision.

Since then, he has spent time focused on his political career in the Philippines, where he has served as a senator and made an unsuccessful run for the presidency in 2022. Subsequently, rumblings of a possible return to the boxing ring had grown.

Boxing’s only eight-division world champion, Pacquiao has beaten the likes of Shane Mosley, Miguel Cotto and Erik Morales.

He lost to Floyd Mayweather Jr. by unanimous decision in 2015, when the two boxers combined to produce an estimated $400 million in pay-per-view buys – believed to be the biggest take in the sport’s history.

This post appeared first on USA TODAY

The S&P 500 ($SPX) wrapped up Tuesday just below its intraday midpoint and posted one of the narrowest ranges we’ve seen in the past two months. That’s a clear sign traders are reluctant to take major bets ahead of Wednesday’s 2:00 PM ET Federal Open Market Committee (FOMC) decision.

And honestly, this caution makes sense. If we look back at how the stock market has reacted following the first two FOMC meetings of 2025, there has been a mix of hesitation and sharp moves.

Below is an updated chart marking each FOMC date since 2024 alongside the S&P 500. After the late January meeting, the S&P 500 zig-zagged to marginal new highs over the next two weeks before the first of two sharp down legs unfolded.

FIGURE 1. FOMC DATES SINCE 2024.

Coincidence or not, the S&P 500 is trading at nearly the same price level now, six weeks later, as it was back then. So, how close are today’s prices compared to the close on March 18, the day before the last Fed meeting?

This close (see chart below):

FIGURE 2. THE S&P 500 IS TRADING VERY CLOSE TO LAST FOMC MEETING LEVELS.

The difference is that the index has been rallying for four weeks, starting from the pivot low on April 7, a month ago today. In March, the S&P 500 was trying to bounce after topping four weeks earlier on February 19. That bounce continued for a few more days before dominant down-trending price action took over.

But over the last few weeks, the dominant trend is definitely higher. So the big question now is: can this mini uptrend resume after this pause?

A Short-Term Setup to Watch

A few days ago, the 14-period relative strength index (RSI) on the two-hour chart grazed the 70-overbought level for the first time since late January (see chart below). Yes, it took a nearly 18% rally in a very short time frame for it to finally happen, but remember, the indicator was coming off its lowest level since the COVID lows. Modest 3–5% pops were enough to trigger overbought readings for much of 2024. Not this time.

As you know, overbought conditions never persist, especially in very short timeframes like this. However, if this rally has anything left in the tank, we’ll see the indicator hit overbought again soon. That may not happen in the next day or two, but if the market reacts negatively to today’s news, but a bid returns soon after, it could keep some of the bullish patterns we’ve been tracking in play. That’s just one scenario, but one we’ll be closely watching.

FIGURE 3. TWO-HOUR CHART OF THE S&P 500.

Bullish Patterns Still Intact

There are two bullish pattern breakouts still in play on the S&P 500 chart:

And barring a very extreme and negative reaction, the patterns will stay alive today, as well.

FIGURE 4. INVERSE HEAD-AND-SHOULDERS AND CUP WITH HANDLE PATTERNS.

FIGURE 5. INVERSE HEAD-AND-SHOULDERS PATTERN IN THE S&P 500.

FIGURE 6. CUP WITH HANDLE PATTERN IN THE S&P 500.

A Bright Spot: Utilities

The Utilities Select Sector SPDR Fund (XLU) was the first sector ETF (and one of the first of all the ETFs we track) to notch a new 50-day high, which it hit on Tuesday. On the weekly chart, it’s clear the ETF is now trying to leverage a multi-month bottoming formation.

This is especially notable because the formation has developed above two bullish pattern breakouts from 2024. Ironically, XLU’s first major breakout of 2024 happened around this time last year (late April), which set the stage for an extremely strong run, at least through late November.

The current snapback is important to watch, given how well XLU has recently capitalized on bullish breakouts. Some upside follow-through from here would also put the former highs back in the crosshairs.

FIGURE 7. WEEKLY CHART OF UTILITIES SELECT SECTOR SPDR (XLU).

Invesco Solar (TAN) Still Has Work to Do

Invesco Solar ETF (TAN) has been rallying since the April lows, much like nearly every ETF we track. On the daily chart, it’s been trying to leverage a bullish cup and handle pattern, a formation we’ve also seen emerge in many other areas. It’s coming off an extremely oversold condition, with its 14-week RSI undercutting 30 for just the third time since 2021. So TAN could see some additional upside from here.

But the ETF will need to do much more to materially improve its long-term technical picture. Nearly every rally has stalled near the key weekly moving averages, all of which continue to slope lower. Selling strength in TAN has been a highly effective strategy since it peaked in early 2021.

FIGURE 8. WEEKLY CHART OF INVESCO SOLAR ETF (TAN).

Bitcoin Holding Up

Bitcoin has held its breakout from two weeks ago quite well so far. The next upside target remains near 103k. Again, regardless of whether or not you follow crypto, seeing the bid continue is a bullish sign for risk appetite across different asset classes, especially equities.

Fun fact: Bitcoin topped a few weeks before the SPX, so it can be a useful leading indicator.

FIGURE 9. BITCOIN BREAKS OUT.

Ethereum Playing Catch-Up

While Ethereum’s extreme relative weakness vs. Bitcoin has continued, it too has rallied over the last few weeks. It’s now close to breaking out from a cup with handle formation. At the same time, it’s testing its now flat 50-day moving average.

The combination of a bullish breakout and a move through the 50-day moving average produced a very strong follow-through rally in November, something Ethereum will try to replicate.

FIGURE 10. ETHEREUM BREAKS ABOVE 50-DAY MOVING AVERAGE.

Final Thoughts

As we head into the Fed decision, we’re seeing a lot of cautious optimism in the charts. Key bullish patterns are still holding, sectors like Utilities are showing strength, and crypto is flashing green.

The next few sessions will be important. If we get a knee-jerk reaction to the Fed, but buyers step in quickly it could set the stage for the next leg higher in this rally.

Stay alert.



Frank Cappelleri is the founder and president of CappThesis, an independent technical analysis newsletter firm. Previously, Frank spent 25 years on Wall Street, working for Instinet, the equity arm of Nomura and Smith Barney. Frank’s various roles included being an equity sales trader, technical analyst, research sales specialist and desk strategist. Frank holds the CFA and CMT designations and is a CNBC contributor.

https://cappthesis.com

https://www.youtube.com/@cappthesis

https://twitter.com/FrankCappelleri/

https://www.linkedin.com/in/frank-cappelleri-cfa-cmt-a319483/

With all eyes and ears on this week’s Fed meeting, it’s worth taking a big step back to reflect on conditions related to momentum, breadth, and leadership.  And while the rally of the early April lows has been significant, the S&P 500 and Nasdaq 100 now face considerable resistance at the 200-day moving average.

With that backdrop in mind, here are three charts we’re watching that have not yet signaled an “all clear” for risk assets.

Our Market Trend Model Remains Medium-Term Bearish

Long-time market newsletter author Paul Montgomery used to point out that the most bullish thing the market can do is go up. The way we make this simple assessment of market trend is using our Market Trend Model.

As of last Friday’s close, our Market Trend Model shows a short-term bullish signal, given the strength off the early April low. The medium-term model, however, remains bearish, as the recent bounce is still defined as a bear market rally. If the S&P 500 can push above its own 200-day moving average, that would likely be enough to move the medium-term model to the bullish side for the first time since October 2023.

Over the years, I’ve found the Market Trend Model to be a fantastic way of separating the short-term “flickering ticks” of day-to-day market movements from the more significant shifts in sentiment from bullish to bearish. And by staying on the right side of this model, I’ve been able to capture most of the market upside, and more importantly, avoid disastrous bear phases!


Don’t miss our daily market recap show, CHART THIS with David Keller, CMT. We’ll track how these charts evolve through the course of the week, highlight key stocks on the move, and boil down the most important market themes from a technical perspective. Join us live every trading day at 5pm ET, or catch the replay on our YouTube channel!


Will Key Stocks Breakout Above the 200-Day?

While the S&P 500 and Nasdaq 100 are testing their own 200-day moving averages, many S&P 500 members are in a very similar position. At the April 2025 market low, less than 10% of the S&P 500 stocks were above their 50-day moving average. That reading has reached almost 60% this week as literally half of the S&P 500 members have regained this short-term moving average.

While the bottom panel shows the percent of stocks above the 50-day moving average, the next panel up displays the percent of S&P 500 members above their 200-day moving average. While this has also increased over the last month, it still remains below 50%.

The countertrend rally in March 2025 saw this indicator go up to 50% and then reverse lower, providing a warning sign of further lows to come. Will we see a similar stall in this indicator in May 2025? If so, that could indicate a retest of the April low. On the other hand, if both of these gauges push above 50%, then investors should brace for much further upside for the S&P 500.

Offense Needs to Dominate Defense

Leadership themes could become incredibly important, as many leading growth stocks remain in a position of technical weakness. And unless the top growth stocks go into full rally mode, it’s hard to imagine meaningful upside for the S&P 500 and Nasdaq 100. One way to consider this relationship is to chart the ratio between Consumer Discretionary and Consumer Staples.

The top panel shows the cap-weighted sector ETFs, and the bottom panel shows the same ratio using equal-weighted sector ETFs. Both of these ratios made a major peak in Q1 2025, and both of them trended lower into a mid-April low. Over the last three weeks, we’ve seen a dramatic upside reversal in these offense-defense rations, indicating a rotation from defensive to offensive positioning.

Quite simply, I don’t see the major averages pushing higher unless these ratios continue to gain ground to the upside. We have observed strength in some Consumer Staples names, from Kroger (KR) to Coca Cola (KO), but it would take charts like Amazon (AMZN) making a significant move higher to give the S&P 500 any real chance of pushing above its own 200-day moving average. This ratio moving higher would confirm that “things you want” are outperforming “things you need”, and that has bullish implications for risk assets.

Investors are facing more uncertainty than ever as we brace for the latest Fed announcement, the newest tariff headline, and mixed results in the form of economic indicators. By watching charts like these, and keeping a watchful eye on the updated Market Summary page, StockCharts users can approach these markets with confidence.

RR#6,

Dave

P.S. Ready to upgrade your investment process? Check out my free behavioral investing course!


David Keller, CMT

President and Chief Strategist

Sierra Alpha Research LLC


Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

The author does not have a position in mentioned securities at the time of publication. Any opinions expressed herein are solely those of the author and do not in any way represent the views or opinions of any other person or entity.

In this video, Joe shares how to trade MACD signals using multiple timeframes, and how to spot stock market pullback setups that can help to pinpoint a great entry off a low. He then reviews sector performance to identify market leadership, covers key chart patterns, and discusses a looming bearish signal on QQQ and IWM. The video wraps with technical analysis on popular viewer-submitted stock symbols, including REAL, PSTG, and more.

The video premiered on May 7, 2025. Click this link to watch on Joe’s dedicated page.

Archived videos from Joe are available at this link. Send symbol requests to stocktalk@stockcharts.com; you can also submit a request in the comments section below the video on YouTube. Symbol Requests can be sent in throughout the week prior to the next show.